NVNO — enVVeno Medical Corp

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1661053 ·
Last close
$5.77
Market Cap
$4.01M
52W High
$14.66
52W Low
$5.70
ADV30
35,825
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -3,796,000 -3,600,000 22,660,000 2,841,000 1,990,000
Mar 2026 0 — -4,062,000 -3,849,000 26,097,000 2,597,000 2,350,000
Dec 2025 0 — -4,013,000 -3,736,000 29,562,000 3,065,000 2,432,000
Sep 2025 0 — -4,883,000 -4,539,000 32,352,000 1,544,000 2,905,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-14,622,000
Investing CF
$14,270,000
Financing CF
$1,023,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-30.83
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-178,776,000
Inventory
—
Receivables
—
ST Investments
$18,645,000
EBIT TTM
$-16,754,000
Pretax Income TTM
$-15,724,000
Interest Exp TTM
—
Analysts
1

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -20,899,000 -19,472,000 29,562,000 2,432,000 27,130,000 -15,568,000
Dec 2024 0 -23,826,000 -21,819,000 44,954,000 2,795,000 42,159,000 -16,838,000
Dec 2023 0 -25,238,000 -23,516,000 48,635,000 2,435,000 46,200,000 -18,858,000
Dec 2022 0 -24,932,000 -24,669,000 41,661,000 2,932,000 38,729,000 -15,619,000

TTM Snapshot

Revenues TTM
$3,359,000
NetIncome TTM
$-15,724,000
OpCashFlow TTM
—
Assets (Latest)
$22,660,000
Forward EPS
$-6.22

Peers — same industry

TickerNameMarket CapLastDaily %
TUTH Standard Dental Labs Inc. $4.10M $0.13 —
ICU SeaStar Medical Holding Corp $4.15M $0.78 —
SNOA Sonoma Pharmaceuticals, Inc. $4.22M $0.83 —
OSRH OSR Health, Inc. $3.51M $0.10 —
MHUAF Meihua International Medical Technologies Co., Ltd. $4.71M $5.50 —

News headlines (Yahoo Finance, 1h cache)

enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
2026-11-02 13:43 · Yahoo
enVVeno Medical Reports Third Quarter 2026 Financial Results and Prepares to Treat First Patients in FDA-Approved TAVVE Pivotal Study
2026-10-30 13:30 · Yahoo
enVVeno Medical Releases New Episode of "WTF" Video Series Featuring CEO Rob Berman
2026-10-21 12:44 · Yahoo
enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal Trial
2026-10-02 12:44 · Yahoo
enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series
2026-09-16 12:50 · Yahoo
enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference
2026-08-27 13:01 · Yahoo
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
2026-07-31 12:30 · Yahoo
enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment
2026-07-15 12:30 · Yahoo
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
2026-07-07 12:29 · Yahoo
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
2026-06-22 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.